Show Me The Evidence

Professor Anthony Gallagher talks to Professor Serge Boveda, co-head of department at Clinique Pasteur in Toulouse, principal investigator for the European Commission grant for ERIS (the European Research Institute on Simulation) and president-elect of the European Heart Rhythm Association. Serge trained in the early 1990s, when interventional electrophysiology was brand new and almost nobody in Europe could teach it. He explains how the specialty and its training have changed since then, how fellows learn today, and why he set up ERIS to train the next generation on technologies that change faster than any university syllabus.

The conversation then turns to the 2026 EHRA scientific statement on digitally assisted learning, which Serge led and on which Tony was a co-author. The statement puts Proficiency-Based Progression (PBP) at the centre of the proposed training and certification pathway. Serge explains why simulation is a tool and not a magic bullet, why every trainee must be assessed before they touch a patient, why the Halstedian model needs modernising rather than burying, and how universities, scientific societies and device manufacturers should share responsibility for training.

Chapters
0:00 Introduction
0:53 What is an electrophysiologist?
2:26 How Serge trained, and why his training is not finished
5:30 How electrophysiology practice has changed since the 1990s
9:16 How the training of fellows has changed
11:28 ERIS: the European Research Institute on Simulation
15:17 Is simulation a tool or a magic bullet?
17:37 Lessons from the first year of ERIS
21:06 The EHRA scientific statement on digitally assisted learning
26:50 Where the PBP idea came from
29:17 Was he surprised by how strongly the statement backed PBP?
32:13 Is the Halstedian training paradigm dead?
35:50 Should trainees be assessed?
38:19 Microcredentials
41:27 Instructions for use and the role of device manufacturers
46:35 Closing

Key studies discussed

EHRA scientific statement on digitally assisted learning (Ernst et al., EP Europace, 2026)
https://doi.org/10.1093/europace/euag081

Expert consensus on performance metrics for cryoballoon ablation training (Boveda et al., European Heart Journal Open, 2025)
https://doi.org/10.1093/ehjopen/oeaf113

From simulator to patient: skill transfer in cardiac device implantation (Mascheroni et al., European Heart Journal Open, 2026)
https://doi.org/10.1093/ehjopen/oeag120

Systematic review and meta-analysis of PBP simulation training (Mazzone et al., Annals of Surgery, 2021)
https://doi.org/10.1097/SLA.0000000000004650

Connect

Professor Serge Boveda on LinkedIn
https://www.linkedin.com/in/serge-boveda-19bb68115/

Professor Anthony G Gallagher on LinkedIn
https://www.linkedin.com/in/anthony-g-gallagher/

Professor Gallagher's publications on Google Scholar
https://scholar.google.com/citations?hl=en&user=rNTScRMAAAAJ&view_op=list_works&sortby=pubdate

#ProficiencyBasedProgression #Electrophysiology #EHRA #SimulationTraining #MedicalEducation #PatientSafety

What is Show Me The Evidence?

Most training is sold on confidence. Show Me The Evidence is built on data.
In every episode we take a single study, clinical trial, or systematic review and work through what it found, how it was designed, and what it means for the way we teach and assess skill. We focus on metrics-based training and proficiency-based progression, the approach that asks learners to demonstrate measurable competence before moving on, and we trace its results across surgical, medical, and professional education.
This is a podcast for learning professionals and medical educators who want more than opinion. Expect plain-language breakdowns of the research, honest discussion of what the evidence does and does not support, and conversations with the people behind the studies.
If you make decisions about how people are trained, we think you deserve to see the evidence first.

My guest today is Professor
Serge Boveda.

Serge and I met a number of
years ago when we were

developing the metrics for a
cryoblation procedure.

Serge is co-headed department

in a Clinique Pasteur

He's principal investigator

for a European Commission grant on

the European Research Institute
& Simulation.

And more importantly, he's
president-elect

of the European Heart Rhythm
Association.

Serge, you're very welcome.

Thank you.

Hi, Tony.

You're a very experienced
electrophysiologist,

or an EP

So, what is an electrophysiologist?

Okay, that's a tricky question
to start.

An electrophysiologist,
as he says in

the name, is an electrician
of the heart.

You know the heart is a muscle

that plays the role of a pump

to bring blood everywhere
in the body.

For this muscle, you need blood
that is brought to the

muscle by coronary arteries and
you need also electricity

to make the contractions
of the muscle.

What is not working with the
electricity of the heart

makes the contractions too slow
or too fast and at maximum

it can be a hurt arrest if it's
too slow or even too fast.

And all the

pathology, the disturbances of
the heart rhythm, so the

rhythm of the heart, the beats
of the heart, is what an

electrophysiologist is
taking care of.

So we are treating the diseases
of the conduction system

that brings the electricity to the
muscle, so to the heart.

This is what is an electrophysiologist.

Do I make it clear?

You make it clear.

Okay, so what training did you go

through to get to this point
in your career?

I mean, I watch you training on

courses and I know you're
pretty good.

So what training did you do
to get to this point?

Okay, my training, to be

completely honest, this
is not finished.

I'm still training today, so I

think that it's a very
long venture.

My situation or the situation of
the electrophysiologist of

my generation is a little bit
special because we were

starting this specialty at
the beginning of the

interventional phase of
electrophysiology.

The operations started in the

90s, so end of the last century.

That was when I was a resident and

training at that time
was very scarce.

It was nearly no centres in Europe
or very few centres,

starting with an electrophysiology
program and it was very

difficult to get trained
at that time.

So I moved to a centre that had a
program of interventional

electrophysiology in Barcelona to
start training in 1993.

And during one full year, I learned
in the operation room

with the pioneers of operation
of this kind of operation

that were done, but at the
very beginning.

Then, obviously, it was

just the first years with this

specialty, we had to improve.

And this is why I say that the
training of my generation

was extremely long because we had
to learn new operations

that were even not existing when
we started this specialty.

So during the maybe 20 years
between the 90s and the

beginning of this century
until 2008, 2010,

new operations, new procedures

were invented and we had to train

all over these years without
stopping.

And training at that time, honestly,
was both very exciting

because we were learning nearly
every day, but it was

difficult because we had to be all
the time open to novel

procedures, novel strategies.

And yes, it was a very, very

interesting, very interesting
time.

Today, this has changed a lot.

So I

infer from that, that the practice
of electrophysiology has

changed considerably from when
you're a young resident.

So what would you say are
the major changes?

Okay,

I will just give you an example.

An operation of electrophysiology,
an ablation, for

example, ablation of some types
of arrhythmia that were a

little bit complex could last in
the 90s or I would say

even about 20 years ago, it
could last five hours.

Basically, the same operation
today is lasting maximum one

hour, sometimes less
than one hour.

So it has been a major change.

It's a completely fun work
for two reasons.

Basically, first, now training
is much more structured.

We have

much more accurate courses.

The theory has improved.

The way to teach also is much
more standardised today.

That's number one.

Number two, the tools and the
technology has changed a lot

and has improved the way of operating
and making the going

faster and even more

efficiently and safely
for the patients.

So I think that that's
very good news,

not only for the patient because
patient today is treated,

I believe, better than 20 years
ago, which makes sense.

We are improving hopefully.

But at the same time, for the new
generations, the new EPs

that are coming now, what we
call the young EPs,

it's much easier.

It's less exciting because

it's not something completely new.

But the good news is that I believe
that they are trained

in a much better way that I was
trained myself because

honestly, I had to train sometimes
alone because it was

difficult to find someone to
work with and to teach.

So today, it's not the case.

And that's very good news.

Today, we have fellows in most
of the European, big

European centres of
electrophysiology.

For example, in my centre, in
Clinique Pasteur Toulouse,

we have five fellows of
EPs every year

coming from all Europe,
even abroad.

And

these guys are staying one full

year, one full year in the lab.

They see in total

more than 2000 ablation, 2000
operation during one year,

when at my time, 20 years ago, the
biggest centre was doing

maybe 500 ablation in a year.

So now they see much more in a
better way, with better

tools, probably with better
proctors.

And

what for me,

I was learning in two years, today,
I think that they can

learn it in six months or maybe
one year maximum.

So yes, it has changed a lot.

It's a completely new world,
a new paradigm.

So I mean, that leads well into
my next question.

So how do you think training for

the EP, how has
that changed

your leadership

in training?

So

how has the training of
fellows changed?

Today's structure, we have a
diploma in France, for

example, it's a full specialty

that is a part of cardiology.

So there is a track where
the young

doctors go in order to learn
electrophysiology.

So it's a very structured

program with teaching courses,
and also

a special centers, so

expert centers where these students,
these fellows are

going in order to start
their training.

That's the first point.

The second point is that they we

have also new ways of teaching.

We have,

for example, simulators
that were not

existing at my time, when I
was a student myself.

And thanks to these new
tools, we can also

make a preparation of the

fellows before entering
into the lab.

So that's a very important phase
in which we can prepare

the young EPs, the young doctors

to go to the the procedure itself.

That's, I believe, a big plus.

But of course, and maybe we can
discuss about that, but

simulation doesn't make it all.

You need to

have simulation embedded into a
very structured program.

And that's maybe the core of the

question, the core of the problem.

And we have to be very careful.

So

you're the leader of the

European Commission funded
grant on

European Research Institute
and simulation.

Can you tell me a bit about what
that's, you know, what the

goal was the function of ERIS?

Yes.

Okay.

ERIS starts from a

philosophical idea that
that I had myself.

I wanted to

provide to propose something in
order to avoid to the young

doctors coming out and
wanting to do

this specialty to have and
to leave the same

problems and the same life that
I had myself for training.

So to improve the way of training,

ERIS, the European Research Institute
on simulation, is

based, as it brings in the
name, on simulation.

But not only on simulation.

Simulation is a part of the case.

It's only a tool that we're
using in the institute

in order to improve the
way of training

the young doctors, the young EPs.

Another idea about Eris, about
this institute, is that

we really believe that it's important
to have a platform

that is providing training for
the new technologies.

We are in a field, as I was
explaining before, that

electrophysiology basically has
started 30 years ago,

maximum, between 20, yes,
30 years ago.

So that means that every year
we're improving with new

tools, new platforms for new

operations, and this is
going very fast.

Even myself, every year, I have
to trade on novel

technologies, novel operations,

novel procedures, novel
strategies.

All this cannot be

assumed by a global university
program.

It's impossible to have a revision
of the program of a

university, of a medical school
every year, to

implement the novel technologies

and to change the program
every year.

Because you will have some technologies
that maybe will

last two, three years and then
will be improved and you

have to change again the program
all the time.

This is something that ERIS
will take care of.

ERIS will implement the novel technologies
when there is an

evolution, when one type of operation
is not used anymore.

We will skip it.

We will take the new one and
the idea is to be very

adaptive to this very fast way

of evolution in our specialty.

This is, I believe, a
very important

proposal in order to get all

the new generation trained to the

more accurate and more efficient
technologies that are

coming in the market every year.

I think that this is a little
bit the idea of ERIS.

So is simulation, is it a tool or
is it the magic bullet?

Oh

yes, of course.

Simulation is a tool.

Simulation is not, again,
simulation is not magic.

Simulation is not something that
will take a young doctor

and make it as an expert after
a couple of hours.

Simulation has to be used as
a tool, as I was saying

before, embedded in a structural
teaching program.

In these fields, the best
way to assess that

young fellows

are improving is to

measure all the

metrics that they are doing well
or not doing well.

The simulator is helping for that
because with a simulator,

you can mimic the operation
without

training directly on a
patient, which

today, in my opinion, is
not acceptable.

It's not acceptable to train
directly on a patient.

You have to start training
on a simulator.

And when a simulator is providing
to the teacher, to the

proctor, all the metrics that the
fellow did well, then

once everything is fine, the fellow
can go to the lab and

work with a proctor, again, not
alone, of course, but with

a proctor work in the real life
on a real patient.

No, I totally agree with
you, Serge.

One of the problems though
is I travel

around the world and teach
on courses.

I think some clinicians think

that simulation is a magic bullet.

I don't think that.

I think it's a tool for the
delivery of a metric-based

curriculum that's derived from
clinicians that are

experienced in the procedure and

preferably metric-based
curriculum.

That's one of the things that ERIS

does, which I think is quite good.

ERIS has been running for
about a year now.

What do you think are the major
lessons learned from the

application of a standardised
course using simulation?

Yes,

ERIS is still in the
learning phase.

We are, as you say, very, very
correctly, we are starting

by the beginning of this
year, 2026.

We provided, until now, seven
courses, in total seven

workshops on all novel
technologies.

And we took lessons from these
seven courses.

Things that worked well was the
interaction between the

fellows and the proctors that
was very, very positive.

The fact that the fellows
could train

in a proper environment on very
high quality simulators

besides faculties that
were very high.

And the fact that we could measure
the metrics was also a

very, very good experience and

very, very positive, I would say.

But we have to put more emphasis
on this part of assessing

all the fellows based
on the metrics.

What we are missing still today
for some kind of operations

are the very accurate metrics
that we need to

record.

We need to have all these metrics
in a very proper way.

And to base the evaluation

purely on that would
be a very good

point.

Another point that is
missing today is

the further evaluation
of the fellows.

Because these fellows, when they
are finished the course,

when the course has been delivered,
they have been

evaluated equitably, if I can say,
just after the course.

And that's good.

That's very good.

But then they are going back
to the hospital.

And what happens there?

What happens in the hospital?

Did they start working in the lab?

Did they start operating?

How much patients did
they operate?

Were there with a proctor?

Are they now in the phase that

they are a principal operator
or not?

What is the outcome of these

operations, et cetera, et cetera?

So all these parts, that
is the follow up,

is still not completely

done.

It's not completely clear.

And we have now put a lot
of effort on this.

This is not an easy way, but

this is a very interesting way.

Because I believe that here we
are setting the basis for

what I would say, the 2.0 education,
where we are now

basing education, not only
on the theory,

on the exams, but also
on the real life.

What happens next?

And this is a little bit the

journey that we want to
put in place.

Now, you're president-elect of
the European Heart Rhythm

Association, which is probably,

well, is one of the most important

professional scientific societies
globally for EPs.

In March, you published a paper

on digitally assisted learning in
cardiac electrophysiology

and cardiac implantable chronic

devices.

Can you summarise

the thrust of that

statement, what it said?

Yes.

I think that this document is very

important because, again,
it's putting

basis of the new way of educating
the EPs, the new

generations that are coming now
of electrophysiologists.

And that's what we wanted to do
in this document, is not

only to say what is working well
now and to explain what we

still need to continue, but also
to explain what is not

working really well and where
we should improve.

And clearly, there

is a lot of room for improvement
in training.

We need to use all the novel

technologies that are
provided today,

like I was saying, not only on the

simulators, but also on
virtual reality.

All the new ways of teaching that
are interesting, we

should embrace them and take
them into the training

programmes of tomorrow and
still of today.

I think that we have to start
today and to improve

during the next years to reach a

very high level quality
of education.

But not only that, technology
is only, as I was saying

before, a part of the problem, a

part of what we have to implement.

What we have to implement is also
the methodology and the

way that we are assessing the new

generation of electrophysiologists.

And in this way of assessing

what we are delivering and what
they are learning and what

they will use in the routine
practice, there is a very

important point that you know
very well, which is the

proficiency-based progression.

And this PBP should be completely
linked with this teaching

programme based on the simulator
in order to

learn with the fellows the way to
improve their skills in

the next month or even years

after the index training
programme.

I think that this is again a journey,
it's not a single day

effort, it's a daily effort during
months, during years and

sometimes during a complete life.

And PBP, it's a very interesting

methodology that makes it standardised
because again,

when you are treating a patient,
I believe that it's not

acceptable that a patient treated
by one doctor in one

hospital will be treated in a
different way than in other

hospitals, in other hands
with another doctor.

I believe that we have to standardise
the training, the

tools that we have today have
a very important

benefit.

I think that they have the possibility
of, let's say,

facilitate a big number, a great
number of operations

because they make them simple,
more simple, not completely

easy to do, but it's much

simpler than in the previous
years.

And we have to take profits
of these

novel technologies because
they can provide

better reproducibility for
the operations.

We have to take this opportunity
to implement also the way

that we are training the fellows
in order to provide also a

more standardised and a more

reproducible training for all
the young generations.

Because at the end of the day,
what we are looking for is

that all patients that will benefit
from an operation will

get the same chances of
success and the

same chances of not having
a complication.

And if we want to have this, if
we aim to reach this goal,

what we need is not only good tools
that are providing more

easy operations, but also good
training programmes that are

providing more reproducible learnings
and more reproducible

learning pathways for the students
in order to get a more

reproducible way of operating
patients.

I

diverge slightly.

At what point did you get that
when we were talking about

the or developing the metrics for
the cryoblation or did

you get that from conversations
in here?

What point did you get that?

Because you're spot on.

Because we are only you
and me, I can

tell you that you are a little
bit my guru.

I think that I got that.

I got that point when we discussed
together and you told me

about the way that you
were approaching

the not really teaching
but evaluation.

And I think that that was maybe
the missing link in my

mind, because I think that

personally I was prepared
to hear this talk.

I was prepared to hear these

words, but I didn't get
because this

is not my work.

This is what you see in a
lot of years now.

And when you explain me your methodology,
I said to myself,

this is what we are missing today
in order to get, as I was

explaining before, the goal
that we are aiming for

again, having the same chances
of success and the same

chances of avoiding complications
in all patients.

And this evaluation, these words,
these sentences that you

told me many years ago, because
it's not something that is

very recent, it's not coming
from yesterday.

But when we met the first
time and when

you made your point on
PBP and all the

journey that you did yourself
in this methodology,

I thought to myself, yes, this
is really interesting.

And we have to implement this
not only in the teaching

programs, but also probably in
the scientific documents.

And this is why today it's something
that is clearly part

and maybe at the core of the last
document we have made together

with ERIS last year for training.

Were you surprised how strongly
the document, the statement

about proficiency-based
progression, that

this is the direction we
have to travel?

Were you surprised?

I mean, I know you led it.

I was on the simulation

group,

but were you surprised that it was

so strong in terms of
what it stilled?

Because it certainly
sets ERA at the

forefront in the world of
where we should go.

Were you surprised?

I'm not surprised.

This is something that for
me, it's logical.

As a president-elect
of the European Heart

Rhythm Association, I want that
our association, that as

you stated rightly, is the most
important profession in

Europe and one of the leaders
in the world with the

Americans, obviously with the

Asians and with Latin America.

I think that we really want to
be the leaders on this.

We really want to be the most
advanced in the way of

preparing the new generations

because the future is
not us anymore.

I'm sorry to say Tony, you and me,
we are not the future,

but our responsibility is to
prepare the future and the

future is the next generation.

And we have to provide them a new
way of learning in order,

again, to improve the quality.

And that's for me not a surprise
to have the PBP,

Proficiency-Based Progressions,
inside the document.

We want to have it because
we believe

that this is probably the
best way to assess

the evolution and to assess the

training of the new generations.

So, yes, I'm very happy to have
this in this document.

And what we need now is
to explain and

is to implement in the training
programs,

first in Europe, of course, but
next in all over the world.

As a member of the, as one of
the co-authors and as a

member of the committee that
discussed simulation, I was

shocked of how forthright and how
accepting the members

were in terms of proficiency-based
progression.

And basically, they accepted
because

of the data that was already
available.

Unfortunately, that's not the

case in all scientific societies.

So,

is the Halsteadian training
paradigm dead?

No, it's not dead.

I think that's,

I am someone that,

as you know, because you know

me a little bit, I like history.

I believe that it's important
to take

base on what our predecessors
have made.

And they made it rightly because
at that time, at the

beginning of the last century,

Halstead, when he was proposing
this training program,

today, it's the way I was trained
myself, in fact, a few

years ago, more or less a few
years, but to be a resident,

the residency program, and the way

that you are completely
involved in this

world of the hospital, of the
operation room, with

proctors, with generations working

together, for me, it's
very positive.

And I think that the Halsteadian

training is not dead, but
we have to make it

modern.

We have to use now what we
have to improve it.

And even if we keep the same structure
with the residency

program, with the training centres,
experts working with

with young fellows in order
to transmit

knowledge, I think that
this is great.

But here we have to add what we
propose today with the

novel tools, the simulators, but
also the methodology that

is coming with these tools, because
these tools without the

method to use them are
not efficient.

They are not serving anything.

They are just like toys that you
are providing for people.

But this is not what we
are looking for.

What we are looking for is a tool
that is used properly,

and also that serves for
evaluating the fellows.

And this is something that we can

implement very well in the
current program.

This is what

we are trying to do with ERIS,
with the project of the EU,

the European Research Institute
on simulation.

Yes.

I mean, I totally agree with it.

I mean, people, they look to me
and they say, well, you've

just killed the Halstedian
training part.

I disagree with that.

I think the Halstedian training
paradigm has evolved.

And what ERIS is doing, what
we're doing, it just makes

the training more efficient
and effective.

And what we sent into the OR or

the cath lab is a pre-trained
novice.

They know how to do the procedure.

They've demonstrated they can do
it in simulation models,

but they still have to
demonstrate it

in the operating room
or the cath lab.

And so what we're doing is

we're shortening the
learning curve.

We're

making sure that the patient is

exposed to less risk from
the learning curve.

So should trainees during and
at the end of their

course, should they be assessed?

Of course, they should
be assessed.

Why?

Look, I take an example, a
very simple example.

I'm used to take this example.

I am working and living in Toulouse,
which is the city of

Airbus, planes, and nobody would
take a plane with a pilot

that has not been trained and
assessed properly.

So would it be fair to have a
doctor that is operating a

patient for the first time without
being training properly

and assessed in the right way?

No, it's not acceptable.

So, yes.

And again, yes, we have not only
to train our young

colleagues with the novel technologies,
with the novel

methodologies, but we have also
to assess them before they

are entering in the lab for
operating the patients.

This is for me mandatory.

And this is probably the basis

for the future of education
in this field.

Including medicine?

It has to be acceptable.

We are professionals, we are
dealing with patients.

This has to be accepted.

For me, I accept even
after 30 years

of experience, I accept
to be assessed.

I work with my colleagues, I
work with my fellows.

When I can improve something,
I will

improve it because this is
our responsibility.

We are operating patients.

Again, a pilot of a plane
that is not

landing properly has to change
his way of landing.

If we don't operate in
the right way,

we have to change our way
of operating.

Yes, of course.

Assessment is necessary.

I mean, I agree with you, but
you are the leadership.

And I'm not sure everybody
will agree with you.

But I totally agree with you and
I think it's the future.

The European Commission
recently has

implemented the idea that certain
professional groups

within medicine have to demonstrate,
or they have to do

courses, and they have
to demonstrate a

performance level to get
microcredentials.

Microcredentials, I think it's
a fabulous idea because

basically the microcredentials

are awarded from universities,

which means they have to be

legally accepted across countries.

Whereas today, if you do a course
in Spain or France,

they don't have to.

If they're awarded through the

universities, they have to
be legally accepted.

Do you think microcredentials

are a good idea or a bad idea?

No, look Tony,

it's the same microcredentials
are necessary.

The university is the house
of knowledge.

So the university is
the place where

we have to base our training
programs.

And the microcredentials

are the proof that these programs
are delivered in the

right way in the house
of knowledge.

And I believe that this is
mandatory and Europe will

improve a lot by spreading these
microcredentials because,

and this is again, you know, the

French were very in favor
of equality.

It's mandatory that the patient
that is treated in Spain,

in Italy, even in Ireland

should be treated in the same way.

I think that it's important that
the microcredentials are

delivering also the standard,
the proof that what is

delivered is delivered in
the proper way.

And with a

background, the support
of the university.

So yes, they are necessary and

they should be tomorrow, probably

at least this is what I hope, the
basis for the education

of the new generations, because
these microcredentials will

be again, the proof that all the
doctors in Europe are

trained in the same way and
in the proper way.

Yeah, no, I totally agree
with that.

Microcredentials are a fabulous

idea, but it has to have teeth.

We need proper standardised metrics,
validated metrics,

benchmarks to make sure that
the same standards are

delivered across the countries.

And that's one of the things that
the clinical trial within

the ERIS, I think that's one
of the most important

functions to demonstrate
unequivocally

that performance levels impact
on outcomes.

The device manufacturers are legally,
legally responsible

for instruction for use training.

Sure.

Published evidence suggests that

most clinicians on the use
of devices and so on,

they don't really know

the instruction for use.

Is that a problem?

It's a big problem.

It's a major problem.

And this is again why ERIS is
important and ERIS and all

these kinds of initiatives,
because

the training programs will be
based not only on PBP, will

be based not only on the

microcredentials, but they will
also be based on the IFU.

The instruction for use
have also to

be implemented in the teaching
programs.

And if you don't do

the operation or the simulation
phase and the training

program in the right way
with the IFUs,

you will not get the
microcredentials.

So that's a part of the
teaching program.

Yes, this is a major problem.

All the doctors should
use the IFUs.

But the company is legally
responsible for it.

So how should deliver
the training?

Should be the professional
societies or ERIS

Obviously we should be delivered,

but the companies or
the clinicians?

Who should be responsible?

That's a very, very important
point.

And I believe, and this is maybe
also a new way from the

Education 2.0, I would say,
a new way of thinking.

I believe, and most probably I'm
not the only one, that the

companies should be also involved

through the IFUs in the
teaching programs.

Of course, the teaching program
is the responsibility of

the university, is delivered
by the

professors, is prepared also
by the university.

But it shouldn't be done

with ignoring the companies
and the IFUs.

The responsibility of the companies
with the IFUs should be

taken in consideration
and even should

be implemented in the teaching
programs.

So

this is a way or so to say, in
a certain way, maybe the

diplomatic way, as you would say,
that we have to involve

in a certain point the companies
in the teaching process.

And this is, again, what as a university
we are responsible

for leading and to propose
in the next year.

I believe that until very recently
the university was also

working a little bit like artists,
ignoring some

other partners that are important
also in the teaching

journey.

And as you say, you're speaking
about the IFUs, and this is

a perfect example where we
should take this in

consideration and also having a
dialogue, a connection, a

discussion with the companies
in order to have these

implementing in the teaching

programs to speak with
the same voice.

Because if we are not saying the
same, then this is another

reason that the doctors are
not using IFUs.

And this is why we should have
a really very efficient

connection with the teaching departments
of the companies.

Because the companies, all the
companies, because they have

the IFUs, have teaching departments,
we should have a

connection with these people.

Yeah, I mean, I think there's
a competition there,

and maybe it's not that healthy,
that the device

manufacturers, obviously, legally,
they're obliged

to do the instruction for use, but
the fact of the matter

is the evidence shows that the
instruction for use as

delivered by them today
is ineffective.

And I think there needs to be a
conversation between the

scientific societies and the

manufacturers about the optimal
way to do this.

Because legally, I mean,

the clinicians, if they deviate
from the instruction for

use, they're not legally covered

by the indemnity of the hospital.

Okay, just

to finish up with

Serge, thank you.

Thank you for the conversation.

As always, it's been a delight

to talk to you and informative.

Thank you.

Thank you very much.

It was a pleasure, Tony,
like always.

Thank you very much.